ISO accreditation for manufacturing facility

RNS Number : 8340T
Omega Diagnostics Group PLC
11 January 2017
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

ISO accreditation for manufacturing facility in Pune, India

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its fully owned Indian subsidiary, Omega Dx (Asia) Pvt. Ltd has received certificates of accreditation from BSI confirming its Quality Management System is compliant with ISO 9001:2008 and ISO 13485:2003.

 

The accreditation covers the manufacturing facility in Pune and ensures that product originating from this site is designed, manufactured and supplied to internationally recognised quality standards. This milestone is an important pre-requisite for CE-Marking the malaria and pregnancy tests produced at this site. CE-Marking is still expected to be achieved by the end of the current financial year.

 

Accreditation also means that products can be supplied for the Indian domestic market with immediate effect and the first commercial sale of one of the Company's malaria tests has now been achieved.

 

Andrew Shepherd, Chief Executive Officer of the Company commented: "We are pleased to have reached this milestone on schedule and look forward to generating a return from the investment to date in this facility."

 

 

Contacts:

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Andrew Shepherd, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director


Jag Grewal, Group Sales and Marketing Director                                                  

 



finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)


Mia Gardner (Corporate Broking)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVRLLIILID
UK 100